Peroxisome proliferator-activated receptor alpha (PPARα) is a known metabolic regulator of lipid metabolism in the gut and liver and is an attractive therapeutic target for metabolic syndromes and NAFLD (16, 17). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.